Detect peripheral arterial disease (PAD) before it becomes irreversible.
FDA 510(k) cleared — VascularAssist Occlusion Triage (VAOT) AI-driven imaging intelligence that helps clinicians identify chronic PAD earlier, with greater confidence.
Chronic PAD often progresses silently.
By the time symptoms appear, intervention windows may already be narrowing.
THE PROBLEM
Too often, PAD is detected after damage has already occurred.
Many vascular conditions progress silently for years.
Early changes are subtle, distributed, and easy to overlook — even with modern imaging.
Imaging provides data. Early risk remains unclear.
Clinical imaging is central to vascular assessment, yet current approaches often focus on visible, late-stage markers.
This leaves a critical gap between available data and actionable early insight.
The cost of late detection is high.
Delayed diagnosis limits preventive options, increases downstream testing, and contributes to avoidable adverse events.
Clinicians are left managing outcomes — rather than preventing them.
The Solution?
A clearer signal, earlier in the process.
GuideAI Health applies advanced AI models to medical imaging to identify early indicators of PAD.
Our platform is designed to support radiologists and clinicians by delivering clear, consistent, and actionable findings — without disrupting existing workflows.
VascularAssist™
AI-powered image activation for enhanced diagnosis and management of PAD.
- Detects subtle disease markers
- Supports consistent interpretation
- Scales across high imaging volumes
Elevate Platform, by GuideAI Health
Seamlessly Integrated AI that Defines the Gold-standard in Vascular Care
High Quality Data
- Curated across disease stages, imaging systems, demographics
- Exclusive access to data from 2,100+ hospitals
Scalable Technology
- On-cloud & on-prem deployment
- Frictionless workflow integration
- No additional imaging required
Advanced AI Models
- Mimics radiologist's diagnostic approach to disease detection
- Novel deep learning architecture
Structured Reporting
- Reduces variability and subjectivity
- Easy-to-interpret and actionable findings for treating clinicians
Benefits
The GuideAI Health difference
Improved outcomes
Prevent adverse cardiovascular events, amputations, and long-term healthcare costs. Early detection fundamentally changes the trajectory of disease, enabling preventive measures when they're most effective.
Find Out MorePARTNERS
Guide AI Valued Partners in AI Clinical Innovation:
Collaborating with industry leaders to advance AI-driven vascular diagnostics from research to clinical practice.
Latest News
Press Release
GuideAI Health Announces Marketing and Communications Programs
GuideAI Health Corp. has engaged Upswitch Media Corp. and BTV-Business Television to execute a coordinated marketing, communications and investor-awareness program to raise awareness of the Company and its AI platform for the detection and characterization of vascular disease.
July 10, 2026
Press Release
GuideAI Health Appoints Renowned Interventional Radiologist Dr. James Benenati to Advisory Board Following FDA 510(k) Clearance of VAOT
GuideAI Health Corp. has appointed James F. Benenati, MD, FSIR — a leading interventional radiologist and Chief Medical Officer of Penumbra, Inc. — to its Advisory Board, building on the recent FDA 510(k) clearance of its VAOT vascular triage software.
July 6, 2026
Press Release
GuideAI Health Corp. Engages Market Maker
July 2, 2026 — Boston, Massachusetts — GuideAI Health Corp. (Cboe CA: GDAI) (the “Company” or “GuideAI”) announces that it has engaged DS Market Solutions Inc. (Address: 1160 Walden Circle, Unit 6, Mississauga, ON, Canada; Contact: David Sears) (“DSM”) as a market maker for its common shares traded on Cboe Canada Inc. (“Cboe Canada”).
July 2, 2026
Clinician-led. Built with deep domain expertise.
Founded by interventional radiologists and supported by leaders in medical imaging, AI, and healthcare innovation.
What's Next?
Submit the form below to test demo
Request a demo
Chronic PAD often progresses silently.